Your browser doesn't support javascript.
loading
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival.
Wirsching, Hans-Georg; Felsberg, Jörg; Prummer, Michael; Moisoiu, Vlad; Lourman, Roxanne; Hertler, Caroline; Antonios, Michelle; Cimino, Patrick J; Roth, Patrick; Gorlia, Thierry; Prins, Robert M; Cloughesy, Timothy; Wen, Patrick Y; Holland, Eric C; Reifenberger, Guido; Weller, Michael.
Afiliação
  • Wirsching HG; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland. hans-georg.wirsching@usz.ch.
  • Felsberg J; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, Düsseldorf, Germany.
  • Prummer M; NEXUS Personalized Health Technologies and Swiss Institute of Bioinformatics, ETH Zurich, Zurich, Switzerland.
  • Moisoiu V; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.
  • Lourman R; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.
  • Hertler C; Department of Radiation Oncology, Competence Center for Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland.
  • Antonios M; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.
  • Cimino PJ; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
  • Roth P; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.
  • Gorlia T; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
  • Prins RM; Department of Neurosurgery, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
  • Cloughesy T; Department of Neurosurgery, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
  • Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Holland EC; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Reifenberger G; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, Düsseldorf, Germany.
  • Weller M; Partner Site Essen/Düsseldorf, German Cancer Consortium (DKTK), Düsseldorf, Germany.
Acta Neuropathol ; 146(4): 647-649, 2023 10.
Article em En | MEDLINE | ID: mdl-37573572
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Acta Neuropathol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Acta Neuropathol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça